Consistently, a subsequent study demonstrated that the concentration of SEMA3A in serum of MM patients was strongly reduced, compared to healthy individuals, and the extent of this reduction was significantly associated with disease progression (19). Here, SEMA3A is linked to Miyoshi myopathy.